Skip to main content
Year archive

Gujarat Themis Biosyn Ltd. — 2021 filings

All 110 regulatory filings released by Gujarat Themis Biosyn Ltd. (GUJTHEM) in 2021, sourced directly from the official regulator.

110 Filings
2021 Period
2021 filings (110)
Filing Released Lang
Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing ....
Regulatory Filings
2021-12-30 English
We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI ....
Regulatory Filings
2021-12-29 English
Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing ....
Regulatory Filings
2021-12-27 English
This is to inform with reference to our letter dated December 1, 2021, regarding One-on-One Concall with Analysts / Investors which was scheduled today, stands cancelled, and the next date ....
Regulatory Filings
2021-12-09 English
Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing ....
Regulatory Filings
2021-12-09 English
This is to inform with reference to our letter dated December 2, 2021, regarding One-on-One Concall with Analysts / Investors which was scheduled today, stands cancelled, and the next date ....
Regulatory Filings
2021-12-07 English
Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing ....
Regulatory Filings
2021-12-02 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-12-02 English
Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing ....
Regulatory Filings
2021-12-01 English
This is to inform with reference to our letter dated November 26, 2021, regarding One-on-One Con calls with Analysts / Investors which were scheduled today, stand cancelled, and the next ....
Regulatory Filings
2021-12-01 English
Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing ....
Regulatory Filings
2021-12-01 English
Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing ....
Regulatory Filings
2021-11-30 English
Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing ....
Regulatory Filings
2021-11-26 English
Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing ....
Regulatory Filings
2021-11-26 English
This has reference to our intimation bearing ref GTBL: CS: BSE-CORR/2021-22 dated 18th November, 2021. The first page of transcript details of Management the Company name -Gujarat Themis ....
Call Transcript
2021-11-19 English
With reference to our letter dated November 8, 2021, and pursuant to Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing ....
Call Transcript
2021-11-18 English
In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we submit herewith the Investors' Presentation of the Company, with ....
Investor Presentation
2021-11-15 English
This has reference to our intimation bearing ref GTBL:CS:BSE-CORR/2021-22 dated 11th November, 2021 inter alia informing you that the Record Date for payment of Interim Dividend is fixed ....
Notice of Dividend Amount
2021-11-12 English
In terms of Regulation 47 of the SEBI (LODR) Regulations, 2015 the Company has published the Unaudited Financial Results for the quarter and half year ended September 30, 2021 in ''Western ....
Regulatory Filings
2021-11-12 English
2. Declaration of an Interim dividend for Financial Year 2021-2022 of Rs.7/-(Rs. 2 plus an additional Rs.5 on the completion of forty years of establishment of the Company) (Rupee Seven ....
Regulatory Filings
2021-11-11 English
2. Declaration of an Interim dividend for Financial Year 2021-2022 of Rs.7/-(Rs. 2 plus an additional Rs.5 on the completion of forty years of establishment of the Company) (Rupee Seven ....
Regulatory Filings
2021-11-11 English
The Board of Directors at its meeting held today, considered and approved the following matters: 1. Un-Audited Financial Results for the Quarter and Half Year ended ....
Regulatory Filings
2021-11-11 English
The Board of Directors at its meeting held today, considered and approved the following matters: 1. Un-Audited Financial Results for the Quarter and Half Year ended ....
Regulatory Filings
2021-11-11 English
We wish to inform you that the Company will host earnings call with analysts and investors at 01:30 p.m. (IST) on November 12, 2021, to discuss financial results of the Company for the ....
Call Transcript
2021-11-08 English
Gujarat Themis Biosyn Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on November 11, 2021 inter alia, to transact the following business: ....
Regulatory Filings
2021-11-02 English
GUJARAT THEMIS BIOSYN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2021 ,inter alia, to consider and approve With respect to the ....
Regulatory Filings
2021-11-02 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-11-01 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-10-12 English
We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2021 received from Link lntime ....
Regulatory Filings
2021-10-08 English
We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI ....
Regulatory Filings
2021-09-29 English
The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Regulatory Filings
2021-09-29 English
In furtherance to intimation under Regulation 10(5) and 10(6) of SEBI (substantial Acquisition of Shares & Take overs) Regulations 2011 ('Takeover Regulations') submitted by Pharmaceutical ....
Regulatory Filings
2021-09-28 English
Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Listing Regulations") read with part A of Schedule Ill of the Listing ....
Regulatory Filings
2021-09-28 English
This is to inform with reference to our letter dated September 22, 2021, regarding One-on-One Concall with Analyst / Investor - Kotak PMS, which was scheduled today, has been rescheduled ....
Investor Presentation
2021-09-23 English
Dear Sir / Madam, Subject: Intimation of Investor/Analyst meet Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, ....
Regulatory Filings
2021-09-22 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pharmaceutical Business Group (India) Ltd & PACs
Regulatory Filings
2021-09-20 English
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pharmaceutical Business Group (India) Ltd
Regulatory Filings
2021-09-20 English
As per the requirement of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, given below are the details of the voting results of the 40th ....
Regulatory Filings
2021-09-19 English
Dear Sir/Madam, In terms of disclosure under Regulation 29 (2) SEBI (Substantial Acquisition of Share and Takeover) Regulations, 2011, we, Pharmaceutical Business Group(India) ....
Regulatory Filings
2021-09-19 English
Dear Sir/Madam, In terms of disclosure under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, we, Pharmaceutical Business Group(India) Limited ....
Regulatory Filings
2021-09-19 English
Dear Sir/ Madam, In terms of disclosure under Regulation 10(6) SEBI (Substantial Acquisition of Share and Takeover) Regulations, 2011, we, Pharmaceutical Business Group(India) ....
Regulatory Filings
2021-09-19 English
This has reference to our submission of proceedings on 17th September, 2021 for 40th Annual General Meeting held on Friday, 17th September, 2021, wherein the Resolution No. 2 was inadvertently ....
AGM Information
2021-09-19 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para A of Part A of Schedule III to ....
Board/Management Information
2021-09-18 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose gist of proceedings of 40th Annual ....
AGM Information
2021-09-17 English
Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing ....
Regulatory Filings
2021-09-17 English
The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pharmaceutical Business Group India Ltd
Regulatory Filings
2021-09-17 English
Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing ....
Regulatory Filings
2021-09-16 English
In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we submit herewith the Investors' Presentation of the Company, with ....
Regulatory Filings
2021-09-13 English
This is in furtherance to our letter dated 24th August, 2021 wherein the Company had submitted its Annual Report along with the Notice of the 40th AGM to be held on Friday, 17th September, ....
Regulatory Filings
2021-09-02 English
In terms of Regulation 47 of the SEBI (LODR) Regulations, 2015, the Company has published the notice in ''Western Times'' (English) edition dated August26, 2021& in ''Western Times'' (Gujarati) ....
Regulatory Filings
2021-08-26 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (as amended) read with Schedule III of the SEBI Listing ....
Regulatory Filings
2021-08-24 English
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of the Annual Report of the Company for the financial ....
Regulatory Filings
2021-08-24 English
In terms of Regulation 47 of the SEBI (LODR) Regulations, 2015 and in compliance with Ministry of Corporate Affairs Circular No. 20/2020 dated 5thMay, 2020 and Circular No. 02/2021 dated ....
Regulatory Filings
2021-08-24 English
In terms of Regulation 47 of the SEBI (LODR) Regulations, 2015 the Company has published the Un-Audited Financial Results for the quarter and three months ended June 30, 2021 in ''Western ....
Interim / Quarterly Report
2021-08-14 English
The Board of Directors at its meeting held today, considered and approved the following matters: 3. Closure of Register of Members and Share Transfer Books from 11thSeptember, ....
Regulatory Filings
2021-08-12 English
The Board of Directors at its meeting held today, considered and approved the following matters: 1. Unaudited Financial Results of the Company for the Quarter ended 30thJune, 2021. ....
Regulatory Filings
2021-08-12 English
The Board of Directors at its meeting held today, considered and approved the following matters: 1. Unaudited Financial Results of the Company for the Quarter ended 30thJune, 2021. ....
Regulatory Filings
2021-08-12 English
GUJARAT THEMIS BIOSYN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2021 ,inter alia, to consider and approve Pleas be informed that ....
Regulatory Filings
2021-08-04 English
We write this in continuation to our letter dated July 24, 2021 on the captioned subject. Pursuant to the Regulation 30 and other applicable SEBI Reguations, we would like to inform ....
Regulatory Filings
2021-07-30 English
Further to our letter dated 26th July, 2021 enclosing therewith the revised disclosure under Regulation 10(5) of SAST 2011, as required by you, we have to explain as under: In ....
Major Shareholding Notification
2021-07-26 English
We refer to your email dated 26th July, 2021 received asking for the revised rectify disclosure under regulation 10(5) of Securities and Exchange Board of India {Substantial Acquisition ....
Regulatory Filings
2021-07-26 English
The Exchange has received the revised disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Regulatory Filings
2021-07-26 English
The Exchange has received the revised disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Regulatory Filings
2021-07-26 English
We write this in continuation to our letter dated 24th July 2021, enclosing herewith intimation under regulation 10(5) of Securities and Exchange Board of India {Substantial Acquisition ....
Regulatory Filings
2021-07-24 English
Pursuant to the Regulation 30 read with Schedule Ill of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 read with Regulation 3 of SEBI (Prohibition of Insider Regulations) ....
Regulatory Filings
2021-07-24 English
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Regulatory Filings
2021-07-24 English
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Regulatory Filings
2021-07-24 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-07-19 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-07-14 English
We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2021 received from Link lntime India ....
Regulatory Filings
2021-07-12 English
The Company had applied to CARE Rating Limited ('CARE') for credit rating and pursuant thereto, the Company has received Rating 'BBB' Stable for Long-term Bank Facilities (Cash Credit) ....
Regulatory Filings
2021-07-06 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-06-30 English
We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI ....
Regulatory Filings
2021-06-30 English
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) , read along with SEBI Circular CIR/CFD/ CMD1/27 /2019 dated February ....
Regulatory Filings
2021-06-29 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-06-11 English
In terms of Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, as amended from time to time, we wish to inform ....
Board/Management Information
2021-06-05 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-06-03 English
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the disclosure of Related ....
Regulatory Filings
2021-05-21 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations andDisclosure Requirements) Regulations, 2015 read with Para A of Part A of Schedule III to ....
Regulatory Filings
2021-05-14 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-05-04 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para A of Part A of Schedule III and ....
Regulatory Filings
2021-05-03 English
In terms of Regulation 47 of the SEBI (LODR) Regulations, 2015 the Company has published the Audited Financial Results for the quarter and year ended March 31, 2021 in ''Western Times'' ....
Regulatory Filings
2021-05-03 English
Appointment of Mr. Rahul Soni (ACS 61305) as Company Secretary and Compliance Officer w.e.f. 12th May, 2021.
Regulatory Filings
2021-05-01 English
Resignation of Mr. Parag Bodha as Company Secretary and Compliance Officer from close of working hours on 11th May, 2021.
Regulatory Filings
2021-05-01 English
Appointment of Ms. Kirandeep Madan (DIN: 00686547) as an Additional Independent Woman Director We have annexed herewith the disclosures pursuant to Regulation 30 of SEBI (Listing ....
Regulatory Filings
2021-05-01 English
The Board of Directors at its meeting held today, transacted/ approved the following matters: 1. Approved the Audited Financial Results for the Quarter and Year ended 31.03 2021. ....
Regulatory Filings
2021-05-01 English
The Board of Directors at its meeting held today, transacted/ approved the following matters: 1. Approved the Audited Financial Results for the Quarter and Year ended 31.03 2021. ....
Regulatory Filings
2021-05-01 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2021-04-30 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-04-29 English
Compliance Certificate - Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended on March 31, 2021.
Regulatory Filings
2021-04-23 English
GUJARAT THEMIS BIOSYN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/05/2021 ,inter alia, to consider and approve 1. To consider the Audited ....
Regulatory Filings
2021-04-23 English
We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2021 received from Link lntime India ....
Regulatory Filings
2021-04-20 English
Enclosed herewith please find Compliance Certificate issued by Mr. Ketan R. Shirwadkar of M/s. KRS & Co., Practicing Company Secretaries for the half year ended 31st March, 2021in terms ....
Regulatory Filings
2021-04-20 English
We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI ....
Regulatory Filings
2021-03-31 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-03-24 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-03-17 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-03-12 English
Further to our intimation dated 24th December 2020 regarding shut down of Company's plant located at 69/C, GIDC Industrial Estate, Vapi, District Valsad, Gujarat for carrying out major ....
Regulatory Filings
2021-03-09 English
In terms of Regulation 47 of the SEBI (LODR) Regulations, 2015 the Company has published the Un-audited Financial Results for the quarter and nine months ended December 31, 2020 in ''Western ....
Regulatory Filings
2021-02-12 English
The Board of Directors at its meeting held today, perused and approved the following matters: 1. Unaudited Financial Results of the Company for the Quarter and Nine months ended ....
Regulatory Filings
2021-02-11 English
The Board of Directors at its meeting held today, perused and approved the following matters: 1. Unaudited Financial Results of the Company for the Quarter and Nine months ended ....
Regulatory Filings
2021-02-11 English
In terms of Regulation 47 of the SEBI (LODR) Regulations, 2015 the Company has published the notice of Board Meeting scheduled to be held on Thursday, February 11, 2021 in ''Western Times'' ....
Regulatory Filings
2021-02-05 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-02-05 English
GUJARAT THEMIS BIOSYN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2021 ,inter alia, to consider and approve the Un-audited Financial ....
Board/Management Information
2021-02-04 English
We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2020 received from Link lntime ....
Regulatory Filings
2021-01-19 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-01-15 English
In terms of Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, as amended from time to time, we wish to inform ....
Board/Management Information
2021-01-14 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-01-08 English
This is to inform you that Company has received a notice on 06th January 2021 from Mr. Si Sung lee, Non-Executive Non-Independent Director of the Company (Representing Yuhan Corporation) ....
Board/Management Information
2021-01-07 English
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited ....
Regulatory Filings
2021-01-06 English